Mathematical models of purine metabolism in man

Mathematical Biosciences

Volumn 151, Issue 1, 1998, Pages 1-49

  Curto, Raul ^a   Voit, Eberhard ^b   Sorribas, Albert ^c   Cascante, Marta ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Biochemical systems theory; General mass action system; Mathematical model; Purine metabolism; S system

Indexed keywords

ARTICLE; ENZYME DEFICIENCY; ENZYME MECHANISM; MATHEMATICAL MODEL; MICHAELIS CONSTANT; PURINE METABOLISM;

ANIMALS; COMPUTER SIMULATION; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; KINETICS; LESCH-NYHAN SYNDROME; MODELS, BIOLOGICAL; PHOSPHORIBOSYL PYROPHOSPHATE; PURINES;

EID: 0031832789     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(98)10001-9     Document Type: Article

References (119)

1. Franco R., Canela E.I. Computer simulation of purine metabolism. European J. Biochem. 144:1984;305.
2. Heinmets F. Supercomputer analysis of purine and pyrimidine metabolism leading to DNA-Synthesis. Cell Biophys. 14:1989;283.
3. Bartel T., Holzhütter H. Mathematical modelling of the purine metabolism of the rat liver. Biochim. Biophys. Acta. 1035:1990;331.
4. Fritzson P. Regulation of nucleotidase activities in animal tisues. Adv. Enzyme Regul. 16:1978;43.
5. Pritchard J.B., Chavez-Peon F., Berlin R.D. Purines: supply by liver to tissues. Am. J. Physiol. 219:1970;1263.
6. Lewis R.A., Haag R.K. Purine nucleoside phosphorilase of bovine liver mithochondria. Adv. Exp. Med. Biol. B. 309:1991;181.
7. Savageau M.A. Biochemical systems analysis. I. Some mathematical properties of the rate law for the component enzymatic reactions. J. Theoret. Biol. 25:1969;365.
8. Savageau M.A. Biochemical systems analysis II. Steady state solutions for an n-poll system using a power-law approximation. J. Theoret. Biol. 25:1969;370.
9. E.O. Voit (Ed.), Canonical Nonlinear Modeling: S-system Approach to Understanding Complexity, Van Nostrand Reinhold, New York, 1991.
10. Curto R., Sorribas A., Cascante M. Comparative characterization of the fermentation pathway of Saccharomyces cerevisiae using biochemical systems theory and metabolic control analysis: model definition and nomenclature. Math. Biosci. 130:1995;25.
11. Cascante M., Curto R., Sorribas A. Comparative characterization of the fermentation pathway of saccharomyces cerevisiae using biochemical systems theory and metabolic control analysis: steady-state analysys. Math. Biosci. 130:1995;51.
12. Sorribas A., Curto R., Cascante M. Comparative characterization of the fermentation pathway of Saccharomyces cerevisiae using biochemical systems theory and metabolic control analysys: model validation and dynamic behaviour. Math. Biosci. 130:1995;71.
13. M.A. Savageau, Biochemical systems analysis: a study of function and design in molecular biology, Addison-Wesley, Reading, MA, 1976.
14. Voit E.O., Savageau M.A. Accuracy of alternative representations for integrated biochemical systems. Biochemistry. 26:1987;6869.
15. Michaelis L., Menten M.L. Die Kinetik der Invertinwirkung. Biochem. Z. 49:1913;333.
16. Savageau M.A., Voit E.O., Irvine D.H. Biochemical systems theory and metabolic control theory: 1. Fundamental similarities and differences. Math. Biosc. 86:1987;127.
17. Savageau M.A., Voit E.O., Irvine D.H. Biochemical systems theory and metabolic control theory: 2. The role of sumation and connectivity relationships. Math. Biosc. 86:1987;147.
18. Hoffman F.O., Hammonds J.S. Propagation of uncertainty in risk assessments: the need to distinguish between uncertainty due to lack of knowledge and uncertainty due to variability. Risk Analysis. 14(5):1994;707.
19. R. Curto, The usefulness of mathematical models in biotechnological and clinical studies: analysis of ethanolic fermentation pathway in Saccharomyces cerevisiae and purine metabolism in humans, Universitat de Barcelona, 1996.
20. T.D. Palella, I.H. Fox, Hyperuricemia and gout in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Ed.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1989, p. 965.
21. Bradford M.J., Krakoff I.H., Leeper R., Balis M.E. Study of purine metabolism in a xanthinuric female. J. Clin. Invest. 47:1968;1325.
22. Edwards N.L., Recker D., Fox I.H. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. J. Clin. Invest. 63:1979;922.
23. Page T., Nyhan W.L., Yu A.L., Yu J. A syndrome of megaloblastic anemia, inmunodeficiency, and exesive nucleotide degradation. Adv. Exp. Med. Biol. 309B:1991;345.
24. Ayvazian J.H., Skupp S. The study of purine utilization and excretion in a xanthinuric man. J. Clin. Invest. 44:1965;1248.
25. Ayvazian J.H., Skupp S. Study of the utilization and excretion of dietary purines in a xanthinuric man. J. Clin. Invest. 45:1966;1859.
26. Snyder F.F., Henderson J.F. Alternative pathways of deoxyadenosine and adenosine metabolism. J. Biol. Chem. 248:1973;5899.
27. Hershfield M.S., Seegmiller J.E. Regulation of de novo purine biosynthesis in human lymphoblasts. J. Biol. Chem. 251:1976;7348.
28. Van Acker K.J., Simonds H.A., Potter C., Cameron J.S. Complete deficiency of adenine phosphoribosyltransferase. N. Engl. J. Med. 297:1977;127.
29. H.A. Simmonds, A.S. Sahota, K.J. Van Acker, Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine lithiasis, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1989, p. 1029.
30. J.D. Geiger, J.I. Nagy, Adenosine deaminase and [3H] nitrobenzylthioinosine as markers of adenosine metabolism and transport in central purinergic systems, in: M. Williams (Ed.), Adenosine and Adenosine Receptors, Humanae Press, Clifton, New Jersey, 1990, p. 225.
31. N.M. Kredich, M.S. Hersfield, Immunodeficiency diseases caused by adenosine deaminase deficiency and Purine nucleoside phosphorylase deficiency, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Ed.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1989, p. 1045.
32. Bontemps F., Van den Berghe G., Hers H.G. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc. Natl. Acad. Sci. USA. 80:1983;2829.
33. E.W. Holmes, J.B. Wyngaarden, Hereditary xanthinuria, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Ed.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1989, p. 1085.
34. Kather H. Pathways of purine metabolism in human adipocytes - Further evidence against a role of adenosine as an endogenous regulator of human fat-cell function. J. Biol. Chem. 265:1990;96.
35. H.R. Horton, L.A. Moran, R.S. Ochs, J.D. Rawn, K.G. Scrimgeour, Transcription and the Processing of RNA, in: H.R. Horton, L.A. Moran, R.S. Ochs, J.D. Rawn, K.G. Scrimgeour (Ed.), Principles of Biochemistry, Prentice-Hall, New Jersey, ch. 21, 1993.
36. Sander G., Topp H., Heller-Schöch G., Wieland J., Schöch G. Ribonucleic acid turnover in man: RNA catabolites in urine as measure for the metabolism of each of the three major species of RNA. Clin. Sci. 71:1986;367.
37. M. Cascante, R. Franco, E.I. Canela, Sensitivity analysis. A common foundation of theories for the quantitative study of metabolic control, in: E.O. Voit (Ed.), Canonical Nonlinear Modeling. S-System Approach to Understanding Complexity, Van Nostrand Reinhold, New York, 1991, pp. 76.
38. Savageau M.A., Sorribas A. Constraints among molecular and systemic properties - Implications for physiological genetics. J. Theoret. Biol. 141:1989;93.
39. Hill C.M., Waight R.D., Bardsley W.G. Does any enzyme follow the Michaelis-Menten equation? Molec. Cell. Biochem. 15:1977;173.
40. M.A. Savageau, Critique of the enzymologists test tube, in: E. Bittar (Ed.), Foundations of Medical Cell Biology, Jai Press, Greenwich, CT, 1992, pp. 45.
41. Savageau M.A. Michaelis-Menten mechanism reconsidered: implications of fractal kinetics. J. Theoret. Biol. 176:1995;115.
42. Peschel, The Predator-Prey Model: Do We Live in a Volterra World? Akademie-Verlag, Berlin, 1986.
43. M.A. Savageau, Cascaded enzymatic mechanisms in: M.A. Savageau (Ed.), Biochemical Systems Analysis: A Study of Function and Design in Molecular Biology, Addison-Wesley, London, 1976, p. 217.
44. M.A. Savageau, Mechanisms of gene action, in: M.A. Savageau (Ed.), Biochemical Systems Analysis: A Study of Function and Design in Molecular Biology, Addison-Wesley, London, 1976, p. 235.
45. M.A. Savageau, Enzyme kinetics in vitro and in vivo: Michaelis-Menten revisited, in: E.E. Bittar (Ed.), Principles of Medical Biology, Jai Press, Greenwich. Connecticut, 1995, p. 93.
46. J.A. Roels, Energetics and Kinetics in Biotechnology, Elsevier, Amsterdam, 1983.
47. Newhouse J.S., Kopleman R. Reaction kinetics on clusters and islands. J. Chem. Phys. 85:1986;6804.
48. E. Kohen, C. Khoen, B. Thorell, G. Wagner, Quantitative aspects of rapid microfluorometry for the study of enzyme reactions and transport mechanisms in single living cells, in: A.A. Thaer, M. Sernetz (Ed.), Fluorescence Techniches in Cell Biology, Springer, New York, 1973, p. 207.
49. Kohen E., Thorell B., Khoen C., Solmon J.M. Studies of metabolic events in localized compartments of the living cell by rapid microspectro-fluorometry. Adv. Biol. Med. Phys. 15:1974;271.
50. Kopleman R. Rate processes on fractals: theory, simulations, and experiments. J. Statist. Phys. 42:1986;185.
51. Sorribas A., Savageau M.A. A comparison of variant theories of intact biochemical systems. 2. Flux-oriented and metabolic control theories. Math. Biosci. 94:1989;195.
52. Seegmiller J.E., Rosenbloom F.M. Enzyme defect associated with a sex-linked human neurological disorder and excesive purine synthesis. Science. 155:1967;1682.
53. Voit E.O. Optimization in integrated biochemical systems. Biotechnol. Bioeng. 40:1992;572.
54. D.C. Lewis, Qualitative analysis of S-systems: Hopf bifurcations, in: E.O. Voit (Ed.), Canonocal Nonlinear Modeling: S-System Approach to Understanding Complexity, Van Nostrand Reinhold, New York, 1991, p. 304.
55. J.B. Wyngaarden, W.N. Kelley, Gout, in: J.B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein, M.S. Brown (Ed.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1983, p. 1043.
56. Kamatani N., Kuroshima S., Terai Ch., Hakoda M., Nishioka K., Mikanagi K. Diagnosis of genotypes for AdeninePhosphoribosyltransferase (APRT) deficiency. Adv. Exp. Med. Biol. 253A:1989;51.
57. Giacomello A., Salerno C. Possible metabolic basis for GTP depletion in red cells of patients with PRPP synthetase superactivity. Adv. Exp. Med. Biol. 309B:1991;253.
58. Pillwein K., Chiva P., Knoflach A., Czermak B., Schuster K., Gersdorf E., Ausserer B., Murr C., Goebl R., Stockhammer G., Maier H., Kostron H. Purine metabolism of human glioblastoma invivo. Cancer Res. 50:1990;1576.
59. Goodman M.N., Lowenstein J.M. The purine nucleotide cycle. Studies of ammonia production by skeletal muscle in situ and in perfused preparations. J. Biol. Chem. 252:1977;5054.
60. Siems W.G., Grune T., Schmidt R., Uhlig R., Gerber G., Tikhonov Y.V., Pimenov A.M., Toguzov R.T. Purine nucleotides, nucleosides and nucleobases of liver, skeletal muscle, blood and tumor cells during the growth of Erlich Ascites tumor in mice. Adv. Exp. Med. Biol. 309A:1991;113.
61. Grune T., Siems W.G., Gerber G., Uhlig R. Determination of the ultraviolet absorbency and radioactivity of purine compounds separated by high-performance liquid-chromatography - Application to metabolic flux rate analysis. J. Chromatogr. 553:1991;193.
62. Barber J.R., Morimoto B.H., Brunauer L.S., Clarke S. Metabolism of S-adenosyl-L-methionine in intact human erythrocytes. Biochim. Biophys. Acta. 887:1986;361.
63. Oden K.L., Clarke S. S-adenosyl-L-metionine synthase from human erythrocytes: role in the regulation of cellular S-adenosylmethionine levels. Biochemistry. 22:1983;2978.
64. Grune T., Siems W., Uhlig R., Langen P., Gerber G. Changes of purine nucleotide metabolism of Erlich ascites cells during transition of tumor growth. Adv. Exp. Med. Biol. 309A:1991;109.
65. de Verdier C.H., Ericson A., Niklasson F., Westman M. Adenine metabolism in man. 1. After intravenous and preoral administration. Scand. J. Clin. Lab. Invest. 37:1977;567.
66. Tabucchi A., Carlucci F., Pagani R., Ciccomascolo F., Lopalco L., Siccardi A. Some aspects of purine nucleotide metabolism in human lymphocytes: nucleotide content in human lymphoblastoid lines transfected with HIV-1. Adv. Exp. Med. Biol. 309A:1991;121.
67. Morgan G., Strobel S., Montero C., Duley J.A., Davies P.M., Simmonds H.A. Raised IMP-dehydrogenase activity in the erythrocytes of a case of purine nucleoside (PNP) deficiency. Adv. Exp. Med. Biol. 309B:1991;297.
68. J.G. Cory, Metabolismo de los nucleótidos purínicos y pirimidínicos, in: T.M. Devlin (Ed.), Bioquímica, Reverte S.A., Barcelona, 1988, p. 618.
69. Kunjara S., Sochor M., Greenbaum A.L., Mclean P. Aspects of the regulation of hepatic phosphoribosyl pyrophosphate formation in the obese (ob/ob) mouse - Relationship to the pentose phosphate pathway. Biochem. Med. Metab. Biol. 49:1993;217.
70. Albe K.R., Wright B.E. Carbohydrate metabolism in dictyostelium discoideum: II. Systems' Analysis. J. Theoret. Biol. 169:1994;243.
71. L. Stryer. DNA y RNA: Las moléculas de la herencia, in: L. Stryer (Ed.), Bioquímica, Reverté S.A., Barcelona, 1988, p. 71.
72. Puig J.G., Fox I.H., Mateos F.A., Jimenez M.L. Adenine-nucleotide turnover in hypoxanthine-guanine phosphoribosyl-transferase deficiency - Evidence for an increased contribution of purine biosynthesis de Novo. Metabolism. 38:1989;410.
73. King M.E., Honeysett J.M., Howell S.B. Regulation of de novo purine synthesis in human bone marrow mononuclear cells by hypoxanthine. J. Clin. Invest. 72:1983;965.
74. Jimenez M.L., Puig J.G., Mateos F.A., Ramos T.H., Melian J.S., Nieto V.G., Becker M.A. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPPS synthetase superactivity. Adv. Exp. Med. Biol. 253A:1989;9.
75. Traut T.W., Ropp P.A., Poma A. Purine nucleoside phosphorylase: allosteric regulation of a dissociating enzyme. Adv. Exp. Med. Biol. 309B:1991;177.
76. Zoref-Shani E., Kessler-Icekson G., Wasserman L., Sperling O. Characterization of purine nucleotide metabolism in primary rat cardiomyocyte cultures. Biochim. Biophys. Acta. 804:1984;161.
77. Whelan J.M., Bagnara A.S. Factors affecting the rate of purine ribonucleotide dephosphorylation in human erythrocytes. Biochim. Biophys. Acta. 563:1979;466.
78. Van Acker K.J., Simonds H.A. Long-term evolution of type 1 Adenine phosphoribosyltransferase (APRT) deficiency. Adv. Exp. Med. Biol. 309B:1991;91.
79. Becker M.A., Puig J.G., Mateos F.A., Jimenez M.L., Kim M., Simmonds H.A. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesisin inherited superactivity of PRPPsynthetase. Adv. Exp. Med. Biol. 253A:1989;15.
80. Harkness R.A. Lesch-Nyhan syndrome: reduced aminoacid concentrations in CSF and brain. Adv. Exp. Med. Biol. 253A:1989;159.
81. Fujimori S., Tagaya T., Yamaoka N., Kamatani N., Akaoka L. Molecular analysis of hypoxanthine-guanine phosphoribosyltransferase deficiency in Japanese patients. Adv. Exp. Med. Biol. 309B:1991;101.
82. Fox I.H., Kelley W.N. Human phosphoribosylpyrophosphate synthetase kinetic mechanism and end product inhibition. J. Biol. Chem. 247:1972;2126.
83. Fox I.H., Kelley W.N. Human phosphoribosylpyrophosphte synthetase, distribution purification and properties. J. Biol. Chem. 246:1971;5739.
84. Berman P.A.M., Human L. Regulation of 5-phosphoribosyl 1-pyrophosphate and of hypoxanthine uptake and release in human erythrocytes by oxypurine cycling. J. Biol. Chem. 265:1990;6562.
85. Holmes E.W. Kinetic, physical, and regulatory properties of amidophosphoribosyltransferase. Adv. Enzyme Regul. 19:1981;215.
86. Holmes E.W., McDonald J.A., McCord J.M., Wyngaarden J.B., Kelley W.N. Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties. J. Biol. Chem. 248:1973;144.
87. Kovarsky J., Evans M.C., Holmes E.W. Regulation of human amidophosphoribosyltransferase: interaction of ortophosphate, PP-ribose-P, and purine ribonucleotides. Canad. J. Biochem. 56:1978;334.
88. Henderson J.F., Brox L.W., Kelley W.N., Rosenbloom F.M., Seegmiller J.E. Kinetic studies of hypoxanthine-guanine phosphoribosyltransferase. J. Biol. Chem. 243:1968;2514.
89. Albe K.R., Butler M.H., Wright B.E. Cellular concentrations of enzymes and their substrates. J. Theoret. Biol. 143:1990;163.
90. Giacomello A., Salerno C. Human hypoxanthine-guanine phosphoribosyltransferase. J. Biol. Chem. 253:1978;6038.
91. Holmsen H., Rozenberg M.C. Adenine nucleotidemetabolism of blood platelets. III Adenine phosphoribosyl transferase and nucleotide formation from exogenous adenine. Biochim. Biophys. Acta. 157:1968;266.
92. Fujimori S., Akaoka I., Sakamoto K., Yamanaka H., Nishioka K., Kamatani N. Common characteristics of mutant adenine phosphoribosyltransferases from four separate Japanese families with 2,8-dihydroxyadenine urolithiasis associated with partial enzyme deficiencies. Hum. Genet. 71:1985;171.
93. Hori M., Henderson J.F. Kinetic studies of adenine phosphoribosyltransferase. J. Biol. Chem. 241:1966;3404.
94. Pugh M.E., Skibo E.B. Inosine monophosphate dehydrogenase from porcine (Sus-scrofa-domestica) thymus - Purification and properties. Comp. Biochem. Physiol. [B]. 105:1993;381.
95. Holmes E.W., Pehlke D.M., Kelley N. Human IMP dehydrogenase kinetics and regulatory properties. Biochim. Biophys. Acta. 364:1974;209.
96. Page T., Bakay B., Nyhan W.L. Human GMP synthetase. Int. J. Biochem. 16:1984;117.
97. Matsuda Y., Ogawa H., Fukutome S., Shiraki H., Nakagawa H. Adenylosuccinate synthetase in rat liver: the existence of two types and their regulatori roles. Biochem. Biophys. Res. Commun. 78:1977;766.
98. Van der Weyden M.B., Kelley W.N. Human Adenilosuccinate Synthetase. Partial purification, kinetic and regulatory properties of the enzyme from placenta. J. Biol. Chem. 249:1974;7282.
99. Ogawa H., Shiraki H., Matsuda Y., Kakiuchi K., Nakagawa H. Purification, crystalization, and properties of adenylosuccinate synthetase from rat skelethal muscle. J. Biochem. 81:1977;859.
100. Stone R.L., Zalkin H., Dixon J.E. Expression, purification, and kinetic characterization of recombinant human adenylosuccinate lyase. J. Biol. Chem. 268:1993;19710.
101. Spector T., Jones T.E., Miller R.L. Reaction mechanism and specificity of human GMP reductase. J. Biol. Chem. 254:1979;2308.
102. Mackenzie J.J., Sorensen L.B. Guanosine 5'-phosphate reductase of human erythrocytes. Biochim. Biophys. Acta. 327:1973;282.
103. Nagel-Starczynowska G., Nowak G., Kaletha K. Purification and properties of AMP-deaminase from human uterine smooth-muscle. Biochim. Biophys. Acta. 1073:1991;470.
104. Yun S., Suelter C.H. Human erythrocyte 5'-AMP aminohydrolase purification and characterization. J. Biol. Chem. 253:1978;404.
105. Nowak G., Kaletha K. Molecular-forms of human heart-muscle AMP deaminase. Biochem. Med. Metab. Biol. 46:1991;263.
106. Nowak G., Kaletha K. Purification and properties of AMP-deaminase from human kidney. Biochem. Med. Metab. Biol. 47:1992;232.
107. Clarke S. Protein carboxyl methyltransferases: two distinct classes of enzymes. Ann. Rev. Biochem. 54:1985;479.
108. Pegg A.E., Williams-Ashman H.G. On the role of S-adenosyl-L-methionoe in the biosynthesis of spermidine by rat prostate. J. Biol. Chem. 244:1969;682.
109. Zimmermann H. 5'-Nucleotidase: molecular estructure and functional aspects. Biochem. J. 285:1992;345.
110. Itoh R., Oka J. Evidence for existence of a cytosol 5'-nucleotidase in chicken heart: comparision of some properties of heart and liver enzymes. Comp. Biochem. Physiol. 81B:1985;159.
111. Itoh R. Purification and some properties of cytosol 5'-nucleotidase from rat liver. Biochim. Biophys. Acta. 657:1981;402.
112. Höglund L., Reichard P. Cytoplasmatic 5'(3')-nucleotidase from human placenta. J. Biol. Chem. 265:1990;6589.
113. Eriksson S., Thelander L., Akerman M. Allosteric regulation of calf thymus ribonucleoside diphosphate reductase. Biochemistry. 18:1979;2948.
114. Boyer P.D. The binding change mechanism for ATP synthase - Some probabilities and possibilities. Biochim. Biophys. Acta. 276:1993;257.
115. Ballard P.L., Williams-Ashman H.G. Isolation and properties of a testicular ribonucleic acid polymerase. J. Biol. Chem. 241:1966;1602.
116. Fisher P.A., Wang T.S., Korn D. Enzymological Characterization of DNA Polymerase alpha, Basic catalytic properties, processivity, and GAP utilization of the homogeneous enzyme from human KB cells. J. Biol. Chem. 254:1979;6128.
117. Strittmatter C.F. Studies on avian xanthine dehydrogenases. Properties and patterns of appearance during development. J. Biol. Chem. 240:1965;2557.
118. P.K. Bondy, L.E. Rosenberg, Duncan's Diseases of Metabolism, Saunders, Philadelphia, 1974.
119. Lathem W., Rodnan G.P. Impairment of uric acid excretion in gout. J. Clin. Invest. 41:1962;1955.